BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30664347)

  • 1. Selected bisphenols and phthalates screened for estrogen and androgen disruption by in silico and in vitro methods.
    Dvorakova M; Kejlová K; Rucki M; Jírová D
    Neuro Endocrinol Lett; 2018 Dec; 39(5):409-416. PubMed ID: 30664347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative methods in vitro for screening of endocrine disruptors.
    Dvořáková M; Kejlová K; Bendová H; Rucki M; Kohout P; Vavrouš A; Jírová D
    Neuro Endocrinol Lett; 2016 Dec; 37(Suppl1):123-131. PubMed ID: 28263540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of estrogen and androgen activity of food contact materials by different in vitro bioassays (YES, YAS, ERα and AR CALUX) and chromatographic analysis (GC-MS, HPLC-MS).
    Mertl J; Kirchnawy C; Osorio V; Grininger A; Richter A; Bergmair J; Pyerin M; Washüttl M; Tacker M
    PLoS One; 2014; 9(7):e100952. PubMed ID: 25000404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico binding of 4,4'-bisphenols predicts in vitro estrogenic and antiandrogenic activity.
    Conroy-Ben O; Garcia I; Teske SS
    Environ Toxicol; 2018 May; 33(5):569-578. PubMed ID: 29392883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
    Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
    Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Mono-(2-Ethylhexyl) Phthalate (MEHP) on Human Estrogen Receptor (hER) and Androgen Receptor (hAR) by YES/YAS In Vitro Assay.
    Kim DH; Park CG; Kim SH; Kim YJ
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31010227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling the H295R with ERα and AR U2OS CALUX assays enables simultaneous testing for estrogenic, anti-androgenic and steroidogenic modalities.
    Nikopaschou MS; Félix A; Mollergues J; Scholz G; Schilter B; Marin-Kuan M; Fussell KC
    Toxicol Sci; 2023 Jul; 194(2):191-208. PubMed ID: 37261848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors.
    Liu X; Sakai H; Nishigori M; Suyama K; Nawaji T; Ikeda S; Nishigouchi M; Okada H; Matsushima A; Nose T; Shimohigashi M; Shimohigashi Y
    Toxicol Appl Pharmacol; 2019 Aug; 377():114610. PubMed ID: 31195007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic in silico modeling of bisphenols to predict estrogen and glucocorticoid disrupting potentials.
    Chen Q; Zhou C; Shi W; Wang X; Xia P; Song M; Liu J; Zhu H; Zhang X; Wei S; Yu H
    Sci Total Environ; 2020 Aug; 728():138854. PubMed ID: 32570315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular interactions of vinclozolin metabolites with human estrogen receptors 1GWR-α and 1QKM and androgen receptor 2AM9-β: Implication for endocrine disruption.
    Habib H; Haider MR; Sharma S; Ahmad S; Dabeer S; Yar MS; Raisuddin S
    Toxicol Mech Methods; 2020 Jun; 30(5):370-377. PubMed ID: 32208804
    [No Abstract]   [Full Text] [Related]  

  • 11. Endocrine Disruptors Acting on Estrogen and Androgen Pathways Cause Reproductive Disorders through Multiple Mechanisms: A Review.
    Amir S; Shah STA; Mamoulakis C; Docea AO; Kalantzi OI; Zachariou A; Calina D; Carvalho F; Sofikitis N; Makrigiannakis A; Tsatsakis A
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33557243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic depsipeptide mycotoxin exposure may cause human endocrine disruption: Evidence from OECD in vitro stably transfected transcriptional activation assays.
    Park Y; Lee HS
    Reprod Toxicol; 2021 Mar; 100():52-59. PubMed ID: 33346041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying potential endocrine disruptors among industrial chemicals and their metabolites--development and evaluation of in silico tools.
    Rybacka A; Rudén C; Tetko IV; Andersson PL
    Chemosphere; 2015 Nov; 139():372-8. PubMed ID: 26210185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds.
    Fabian E; Gomes C; Birk B; Williford T; Hernandez TR; Haase C; Zbranek R; van Ravenzwaay B; Landsiedel R
    Arch Toxicol; 2019 Feb; 93(2):401-416. PubMed ID: 30552464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.
    Ng HW; Zhang W; Shu M; Luo H; Ge W; Perkins R; Tong W; Hong H
    BMC Bioinformatics; 2014; 15 Suppl 11(Suppl 11):S4. PubMed ID: 25349983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of OASIS QSAR Models Using ToxCast™ in Vitro Estrogen and Androgen Receptor Binding Data and Application in an Integrated Endocrine Screening Approach.
    Bhhatarai B; Wilson DM; Price PS; Marty S; Parks AK; Carney E
    Environ Health Perspect; 2016 Sep; 124(9):1453-61. PubMed ID: 27152837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of in silico methods and computational systems biology to explore endocrine-disrupting chemical binding with nuclear hormone receptors.
    Ruiz P; Sack A; Wampole M; Bobst S; Vracko M
    Chemosphere; 2017 Jul; 178():99-109. PubMed ID: 28319747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein.
    Hong H; Branham WS; Ng HW; Moland CL; Dial SL; Fang H; Perkins R; Sheehan D; Tong W
    Toxicol Sci; 2015 Feb; 143(2):333-48. PubMed ID: 25349334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of In Vitro Endocrine Activities of
    Mallia V; Ivanova L; Eriksen GS; Harper E; Connolly L; Uhlig S
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential endocrine disruption mechanism of anthelmintic drug niclosamide by activating estrogen receptors and estrogen-related receptors.
    He S; Li X; Ma JZ; Yang Y; Luo S; Xie XD; Yan BH; Yang J; Luo L; Cao LY
    Toxicology; 2021 Jun; 457():152805. PubMed ID: 33961950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.